Quantum Genomics Société Anonyme (ALQGC.PA)

2.94 €

+0.07 (+2.58%)
Rating:
Recommendation:
-
Symbol ALQGC.PA
Price 2.94 €
Beta 1.019
Volume Avg. 0.10M
Market Cap 80.415M
Shares () -
52 Week Range 1.541-6.185
1y Target Est -
DCF Unlevered ALQGC.PA DCF ->
DCF Levered ALQGC.PA LDCF ->
ROE -53.86% Strong Sell
ROA -43.42% Strong Sell
Operating Margin -
Debt / Equity 94.95% Buy
P/E -
P/B 4.58 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Lionel Segard
Healthcare
Biotechnology
Paris

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.